Aluminium induced endoplasmic reticulum stress mediated cell death in SH-SY5Y neuroblastoma cell line is independent of p53

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Rizvi, Syed Husain Mustafa ^a   Parveen, Arshiya ^a   Verma, Anoop K ^a   Ahmad, Iqbal ^b   Arshad, Md ^c   Mahdi, Abbas Ali ^a  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

^b CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

^c UNIVERSITY OF LUCKNOW   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM; AMYLOID BETA PROTEIN[1-40]; CALCIUM; CASPASE 12; CASPASE 3; CASPASE 9; CELL PROTEIN; CYTOCHROME C; GLUTATHIONE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; PROTEIN NQO1; PROTEIN P21; PROTEIN P53; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL DEATH; CELL STRUCTURE; CONTROLLED STUDY; CYTOTOXICITY TEST; DOWN REGULATION; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVITY; HUMAN; HUMAN CELL; NERVE CELL NECROSIS; NEUROBLASTOMA CELL LINE; OXIDATIVE STRESS; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION;

EID: 84902322568     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0098409     Document Type: Article

References (60)

1. Reitz C, Brayne C, Mayeux R (2011) Epidemiology of Alzheimer disease. Nat Rev Neurol 3: 137-152.
2. The Huntington's Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72: 971-983.
3. Damier P, Hirsch EC, Agid Y, Graybiel AM (1999) The substantia nigra of the human brain II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. Brain 122: 1437-1448. (Pubitemid 29374122)
4. Walton JR (2006) Aluminum in hippocampal neurons from humans with Alzheimer's disease. Neurotoxicology 27: 385-394.
5. Karbouj R (2007) Aluminium leaching using chelating agents as compositions of food. Food Chem Toxicol. 45: 1688-1693.
6. Reinke CM, Breitkreutz J, Leuenberger H (2003) Aluminium in over the-counter drugs: risks outweigh benefits? Drug Saf 26: 1011-1025. (Pubitemid 37452643)
7. Alfrey AC, LeGendre GR, Kaehny WD (1976) The dialysis encephalopathy syndrome, possible aluminium intoxication. N Engl J Med 294: 184-188.
8. Tripathi S, Mahdi AA, Nawab A, Chander R, Hasan M, et al. (2009) Influence of age on aluminium induced lipid peroxidation and neurolipofuscin in frontal cortex of rat brain: a behavioral, biochemical and ultrastructural study. Brain Research 1253: 107-116.
9. Sharma DR, Sunkaria A, Wani WY, Sharma RK, Kandimalla RJ, et al. (2013) Aluminium induced oxidative stress results in decreased mitochondrial biogenesis via modulation of PGC-1α expression. Toxicol Appl Pharmacol 273: 365-380.
10. Yuan CY, Lee YJ, Hsu GS (2012) Aluminum overload increases oxidative stress in four functional brain areas of neonatal rats. J Biomed Sci 19: 51.
11. Satoh E, Okada M, Takadera T, Ohyashiki T (2005) Glutathione depletion promotes aluminum-mediated cell death of pc12 cells. Biol Pharm Bull 28: 941-946. (Pubitemid 40880293)
12. Banasik A, Lankoff A, Piskulak A, Adamowska K, Lisowska H, et al. (2005) Aluminum-induced micronuclei and apoptosis in human peripheral-blood lymphocytes treated during different phases of the cell cycle. Environ Toxicol 20: 402-406. (Pubitemid 41176677)
13. Dewitt DA, Hurd JA, Fox N, Townsend BE, Griffioen KJ, et al. (2006) Perinuclear clustering of mitochondria is triggered during aluminum maltolate induced apoptosis. J Alzheimers Dis 9: 195-205. (Pubitemid 44078645)
14. Johnson VJ, Kim SH, Sharma RP (2005) Aluminum-maltolate induces apoptosis and necrosis in neuro-2a cells: potential role for p53 signaling. Toxicol Sci 83: 329-339. (Pubitemid 40227902)
15. Kroemer G, Galluzzi L, Brenner C (2007) Mitochondrial membrane permeabilization in cell death. Physiol Rev 87: 99-163. (Pubitemid 46209992)
16. Galehdar Z, Swan P, Fuerth B, Callaghan SM, Park DS, et al. (2010) Neuronal apoptosis induced by endoplasmic reticulum stress is regulated by ATF4-CHOP-mediated induction of the Bcl-2 homology 3-only member PUMA. J Neurosci 30: 16938-16948.
17. Nakagawa T, Zhu H, Morishima N, Li E, Xu J, et al. (2000) Caspase-12 mediates endoplasmic reticulum-specific apoptosis and cytotoxicity by amyloid-β. Nature 403: 98-103. (Pubitemid 30038529)
18. Sánchez AM, Martínez-Botas J, Malagarie-Cazenave S, Olea N, Vara D, et al. (2008) Induction of the endoplasmic reticulum stress proteinGADD153/CHOP by capsaicin in prostate PC-3 cells: a microarray study. Biochem Biophys Res Commun 372: 785-791.
19. Martin RB (1986) The chemistry of aluminum as related to biology and medicine. Clin Chem 32: 1797-1806.
20. Berthold RL, Herman MM, Savory J, Carpenter RM, Sturgill BC, et al. (1989) A long-term intravenous model of aluminum maltol toxicity in rabbits: tissue distribution, hepatic, renal, and neuronal cytoskeletal changes associated with systemic exposure. Toxicol Appl Pharmacol 15: 58-74. (Pubitemid 19094134)
21. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63.
22. Yang J, Wu J, Tashino SI, Onodera S, Ikejima T (2007) Critical roles of reactive oxygen species in mitochondrial permeability transisiton in mediating evodiamine-induced human melanoma A375-S2 cell apoptosis. Free Radic Res 41: 1099-1108. (Pubitemid 47470847)
23. Wan CP, Myung E, Lau BH (1993) An automated microfluorometric assay for monitoring oxidative burst activity of phagocytes. J Immunol Methods 159: 131-138.
24. Janssen YM, Sen CK (1999) Nuclear factor kappa B activity in response to oxidants and antioxidants. Methods Enzymol 300: 363-374.
25. Bloom J, Pagano M (2005) Experimental tests to definitively determine ubiquitylation of a substrate. Methods Enzymol. 399: 249-266. (Pubitemid 41772734)
26. Ciccarone V, Spengler BA, Meyers MB, Biedler JL, Ross RA (1989) Phenotypic diversification in human neuroblastoma cells: expression of distinct neural crest lineages. Cancer Res. 49: 219-225. (Pubitemid 19024435)
27. Xie H, Hu L, Li G (2010) SH-SY5Y human neuroblastoma cell line: in vitro cell model of dopaminergic neurons in Parkinson's disease Chin Med J. 123: 1086-1092.
28. Mattson MP (2000) Apoptosis in neurodegenerative disorders. Nat Rev Mol Cell Biol 1: 120-129.
29. Savory J, Mary MH, Ghribi O (2003) Intracellular mechanisms underlying aluminum-induced apoptosis in rabbit brain. J of Inorg Biochem 97: 151-154. (Pubitemid 37152421)
30. Bayani U, Ajay VS, Paolo Z, Mahajan RT (2009) Oxidative stress and neurodegenerative diseases: A review of upstream and downstream antioxidant therapeutic options. Curr Neuropharmacol 7: 65-74.
31. Peng Z, Geh E, Chen L, Meng Q, Fan Y, et al. (2010) Inhibitor of kappaB kinase beta regulates redox homeostasis by controlling the constitutive levels of glutathione. Mol Pharmacol 77: 784-792.
32. Pogue AI, Li YY, Cui JG, Zhao Y, Kruck TP, et al. (2009) Characterization of an NF-kappaB-regulated, miRNA-146a-mediated down-regulation of complement factor H (CFH) in metal-sulfate-stressed human brain cells. J Inorg Biochem 103: 1591-1595.
33. Kobayashi A, Ohta T, Yamamoto M (2004) Unique function of the Nrf2-Keap1 pathway in the inducible expression of antioxidant and detoxifying enzymes. Methods Enzymol 378: 273-286.
34. Tan Y, Ichikawa T, Li J, Si Q, Yang H, et al. (2011) Diabetic downregulation of Nrf2 activity via ERK contributes to oxidative stress-induced insulin resistance in cardiac cells in vitro and in vivo. Diabetes. 60: 625-633.
35. Kurzawski M, Dziedziejko V, Urasińska E, Post M, Wójcicki M, et al. (2012) Nuclear factor erythroid 2-like 2 (Nrf2) expression in end-stage liver disease. Environ Toxicol Pharmacol. 34: 87-95.
36. Kim HJ, Vaziri ND (2010) Contribution of impaired Nrf2-Keap1 pathway to oxidative stress and inflammation in chronic renal failure. Am J Physiol Renal Physiol. 298: 662-671.
37. Paupe V, Dassa EP, Goncalves S, Auchère F, Lönn M, et al. (2009) Impaired nuclear Nrf2 translocation undermines the oxidative stress response in Friedreich ataxia. PLoS One. 4, e4253. doi: 10.1371/journal.pone. 0004253.
38. Lastres-Becker I, Ulusoy A, Innamorato NG, Sahin G, Rábano A, et al. (2012) α-Synuclein expression and Nrf2 deficiency cooperate to aggravate protein aggregation, neuronal death and inflammation in early-stage Parkinson's disease. Hum Mol Genet. 21: 3173-3192.
39. Jin YN, Yu YV, Gundemir S, Jo C, Cui M, et al. (2013) Impaired mitochondrial dynamics and Nrf2 signaling contribute to compromised responses to oxidative stress in striatal cells expressing full-length mutant huntingtin. PLoS One. 8: e57932. doi: 10.1371/journal.pone.0057932.
40. D'Oria V, Petrini S, Travaglini L, Priori C, Piermarini E, et al. (2013) Frataxin deficiency leads to reduced expression and impaired translocation of NF-E2-Related Factor (Nrf2) in cultured motor neurons. Int J Mol Sci.14: 7853-7865.
41. Rizvi F, Shukla S, Kakkar P (2014) Essential role of PH domain and leucine-rich repeat protein phosphatase 2 in Nrf2 suppression via modulation of Akt/GSK3β/Fyn kinase axis during oxidative hepatocellular toxicity. Cell Death Dis. 5: e1153.doi: 10.1038/cddis.
42. Shen Y, White E (2001) p53-dependent apoptosis pathways. Adv Cancer Res 82: 55-84. (Pubitemid 32613382)
43. Tweddle DA, Malcolm AJ, Cole M, Pearson AD, Lunec J (2001) p53 cellular localization and function in neuroblastoma: evidence for defective G(1) arrest despite WAF1 induction in MYCN-amplified cells. Am J Pathol. 158: 2067-2077. (Pubitemid 32545192)
44. Ronca F, Chan S, Yu V (1997) 1-(5-Isoquinolinesulfonyl)-2- methylpiperazine induces apoptosis in human neuroblastoma cells SH-SY5Y through a p53 dependent pathway. J Biol Chem. 272: 4252-4260. (Pubitemid 27078495)
45. Vogan K, Bernstein M, Leclerc JM, Brisson L, Brossard J, et al. (1993) Absence of p53 gene mutations in primary neuroblastoma. Cancer Res. 53: 5269-5273. (Pubitemid 23333398)
46. Hosoi G, Hara J, Okamura T, Osugi Y, Ishihara S, et al. (1994) Low frequency of the p53 gene mutations in neuroblastoma. Cancer 1994, 73: 3087-3093. (Pubitemid 24170786)
47. Cui H, Schroering A, Ding HF (2002) p53 Mediates DNA Damaging Drug-induced Apoptosis through a Caspase-9-dependent Pathway in SH-SY5Y Neuroblastoma Cells. Molecular Cancer Therapeutics 1: 679-686.
48. Chen L, Malcolm AJ, Wood KM, Cole M, Variend S, et al. (2007) p53 is nuclear and functional in both undifferentiated and differentiated neuroblastoma. Cell Cycle. 6: 2685-96. (Pubitemid 350224053)
49. Rodriguez-Lopez AM, Xenaki D, Eden TOB, Hickman JA, Chresta CM (2000) MDM2 Mediated Nuclear Exclusion of p53 Attenuates Etoposide-Induced Apoptosis in Neuroblastoma Cells Mol Pharmacol 59: 135-143.
50. Daniela U, Teresina C, Enza B, Luigi R, Piergiovanni G, et al. (2002) Selective impairment of p53-mediated cell death in fibroblasts from sporadic Alzheimer's disease patients. J of Cell Sci 115: 3131-3138.
51. Yoshida H (2007) ER stress and diseases. FEBS J 274: 630-658.
52. Nozaki S, Sledge GW Jr, Nakshatri H (2001) Repression of GADD153/CHOP by NF-kappaB: a possible cellular defense against endoplasmic reticulum stress-induced cell death. Oncogene 20: 2178-2185. (Pubitemid 32424012)
53. Görlach A, Klappa P, Kietzmann T (2006) The endoplasmic reticulum: folding, calcium homeostasis, signaling, and redox control. Antioxid Redox Signal 8: 1391-1418. (Pubitemid 44726319)
54. Coleman PD, Yao PJ (2003) Synaptic slaughter in Alzheimer's disease. Neurobiol Aging 24: 1023-1027. (Pubitemid 37487880)
55. Marwarha G, Raza S, Prasanthi JRP, Ghribi O (2013) Gadd153 and NF-kB Crosstalk Regulates 27-Hydroxycholesterol-Induced Increase in BACE1 and b-Amyloid Production in Human Neuroblastoma SH-SY5Y Cells. PLoS One. 8: e70773. doi: 10.1371/journal.pone.
56. Paula-Lima AC, Adasme T, SanMartin C, Sebollela A, Hetz C, et al. (2011) Amyloid β-peptide oligomers stimulate RyR-mediated Ca2+ release inducing mitochondrial fragmentation in hippocampal neurons and prevent RyR-mediated dendritic spine remodeling produced by BDNF. Antioxid Redox Signal 14: 1209-1223.
57. Querfurth HW, Selkoe DJ (1994) Calcium ionophore increases amyloid-beta peptide production by cultured cells. Biochemistry 33: 4550-4561. (Pubitemid 24145103)
58. Green KN, LaFerla FM (2008) Linking calcium to A beta and Alzheimer's disease. Neuron. 59: 190-194. (Pubitemid 352033693)
59. Bojarski L, Herms J, Kuznicki J (2008) Calcium dysregulation in Alzheimer's disease. Neurochem Int 52: 621-633.
60. Stine WB, Dahlgren KN, Krafft GA, Ladu MJ (2003) In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis. J Biol Chem 278: 11612-11622. (Pubitemid 36792723)